The Monalizumab Biosimilar Anti-NKG2A Antibody is a revolutionary product designed for research purposes related to NKG2A, a cell surface receptor known to regulate immune responses. This antibody, derived from innovative biosimilar technology, is highly specific and reactive with human samples, making it an invaluable tool for studies in immunology and cancer research.Through binding to the NKG2A protein, this antibody enables precise detection and analysis in various cell types, allowing researchers to gain insights into the role of NKG2A in immune regulation and its potential therapeutic implications.
With its ability to modulate immune responses, NKG2A has emerged as a promising target for investigating diseases such as cancer, autoimmune disorders, and viral infections.By utilizing the Monalizumab Biosimilar Anti-NKG2A Antibody in their research, scientists can advance their understanding of immune regulation mechanisms and explore new therapeutic strategies for addressing complex diseases. This cutting-edge product offers a novel approach to studying NKG2A and holds great potential for driving breakthroughs in the field of immunotherapy.
Product Name:
Monalizumab (Anti-NKG2A) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0085
Target:
NKG2A
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
